Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGGF1P10 (angiogenic factor with G-patch and FHA domains 1 pseudogene 10) is a processed pseudogene sharing homology with the protein-coding AGGF1 gene. As a pseudogene, AGGF1P10 lacks the ability to produce functional protein products, following the standard definition in human genomics[2][4]. Pseudogenes can have regulatory roles at the RNA level—such as acting as microRNA decoys, generating regulatory noncoding RNAs, or influencing gene expression through competition for RNA stability factors—but there is no specific evidence for AGGF1P10 performing these functions[1][4]. AGGF1P10 is not considered a therapeutic target, receptor, enzyme, or druggable protein[5][3]. Its main classification is as a noncoding genomic segment homologous to functional genes, with unknown or speculative biological function[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenic factor with G-patch and FHA domains 1 pseudogene 10 (AGGF1P10).